AJR ARRS Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME Credit
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sofocleous, C. T.
Right arrow Articles by Brown, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sofocleous, C. T.
Right arrow Articles by Brown, K. T.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
DOI:10.2214/AJR.07.2198
AJR 2007; 189:883-889
© American Roentgen Ray Society

Clinical Observations

Radiofrequency Ablation in the Management of Liver Metastases from Breast Cancer

C. T. Sofocleous1, R. G. Nascimento1, M. Gonen2, M. Theodoulou3, A. M. Covey1, L. A. Brody1, S. M. Solomon1, R. Thornton1, Y. Fong4, G. I. Getrajdman1 and K. T. Brown1

1 Section of Interventional Radiology and Image Guided Therapies, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Rm. H118, New York, NY 10021.
2 Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.
3 Section of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.
4 Section of Gastrointestinal Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.

OBJECTIVE. Systemic chemotherapy remains the standard treatment for patients with breast cancer hepatic metastases. Resection of metastases has survival advantages in a small percentage of selected patients. Radiofrequency ablation has been used in small numbers of selected patients. This small series was undertaken to review our experience with radiofrequency ablation in the management of patients with breast cancer hepatic metastases.

CONCLUSION. Radiofrequency ablation of breast cancer hepatic metastases is safe and may be used to control hepatic deposits in patients with stable or no extrahepatic disease.

Keywords: breast cancer • breast cancer metastases • liver metastases • liver tumors • radiofrequency ablation


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.